Animal models for investigating chronic pancreatitis

Fibrogenesis and Tissue Repair

Volumn 4, Issue 1, 2011, Pages

  Aghdassi, Alexander A ^a   Mayerle, Julia ^a   Christochowitz, Sandra ^a   Weiss, Frank U ^a   Sendler, Matthias ^a   Lerch, Markus M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CERULETIDE; TRYPSINOGEN;

ALCOHOL CONSUMPTION; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; EXPERIMENTAL MODEL; GENE EXPRESSION PROFILING; GENETIC MODEL; HISTOLOGY; HUMAN; NONHUMAN; PANCREAS DUCT LIGATION; PANCREATIC STELLATE CELL; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; TRANSGENICS;

EID: 84856606842     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-4-26     Document Type: Review

References (149)

1. Ammann RW, Akovbiantz A, Largiader F, Schueler G. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology 1984, 86:820-828.
2. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001, 120:682-707. 10.1053/gast.2001.22586, 11179244.
3. Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984, 25:756-759. 10.1136/gut.25.7.756, 1432589, 6735257.
4. Chari ST, Singer MV. The problem of classification and staging of chronic pancreatitis. Proposals based on current knowledge of its natural history. Scand J Gastroenterol 1994, 29:949-960. 10.3109/00365529409094869, 7839103.
5. Andersen BN, Pedersen NT, Scheel J, Worning H. Incidence of alcoholic chronic pancreatitis in Copenhagen. Scand J Gastroenterol 1982, 17:247-252. 10.3109/00365528209182047, 7134849.
6. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A 1978, 86A:367-373.
7. O'Sullivan JN, Nobrega FT, Morlock CG, Brown AL, Bartholomew LG. Acute and chronic pancreatitis in Rochester, Minnesota, 1940 to 1969. Gastroenterology 1972, 62:373-379.
8. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, DiMagno EP, Andren-Sandberg A, Domellof L, Di Francesco V. Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am J Gastroenterol 1994, 89:1467-1471.
9. Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996, 111:224-231. 10.1053/gast.1996.v111.pm8698203, 8698203.
10. Bordalo O, Goncalves D, Noronha M, Cristina ML, Salgadinho A, Dreiling DA. Newer concept for the pathogenesis of chronic alcoholic pancreatitis. Am J Gastroenterol 1977, 68:278-285.
11. Schoenberg MH, Buchler M, Pietrzyk C, Uhl W, Birk D, Eisele S, Marzinzig M, Beger HG. Lipid peroxidation and glutathione metabolism in chronic pancreatitis. Pancreas 1995, 10:36-43. 10.1097/00006676-199501000-00005, 7899458.
12. Braganza JM. Pancreatic disease: a casualty of hepatic "detoxification"?. Lancet 1983, 2:1000-1003.
13. Braganza JM, Wickens DG, Cawood P, Dormandy TL. Lipid-peroxidation (free-radicaloxidation) products in bile from patients with pancreatic disease. Lancet 1983, 2:375-379.
14. Uden S, Bilton D, Nathan L, Hunt LP, Main C, Braganza JM. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther 1990, 4:357-371.
15. Freedman SD, Sakamoto K, Venu RP. GP2, the homologue to the renal cast protein uromodulin, is a major component of intraductal plugs in chronic pancreatitis. J Clin Invest 1993, 92:83-90. 10.1172/JCI116602, 293537, 8326020.
16. Sahel J, Sarles H. Modifications of pure human pancreatic juice induced by chronic alcohol consumption. Dig Dis Sci 1979, 24:897-905. 10.1007/BF01311942, 510088.
17. Kloppel G. Pathology of chronic pancreatitis and pancreatic pain. Acta Chir Scand 1990, 156:261-265.
18. Kloppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas 1993, 8:659-670. 10.1097/00006676-199311000-00001, 8255882.
19. Blaine SA, Ray KC, Branch KM, Robinson PS, Whitehead RH, Means AL. Epidermal growth factor receptor regulates pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2009, 297:G434-441. 10.1152/ajpgi.00152.2009, 2739824, 19608732.
20. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998, 43:128-133. 10.1136/gut.43.1.128, 1727174, 9771417.
21. Apte M, Pirola R, Wilson J. New insights into alcoholic pancreatitis and pancreatic cancer. J Gastroenterol Hepatol 2009, 24(Suppl 3):S51-56.
22. Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Beger HG, Adler G. Balance of expression of genes-coding for extracellular-matrix proteins and extracellular-matrix degrading proteases in chronic-pancreatitis. Z Gastroenterol 1994, 32:221-225.
23. Mews P, Phillips P, Fahmy R, Korsten M, Pirola R, Wilson J, Apte M. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 2002, 50:535-541. 10.1136/gut.50.4.535, 1773172, 11889076.
24. Vonlaufen A, Xu Z, Daniel B, Kumar RK, Pirola R, Wilson J, Apte MV. Bacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal model. Gastroenterology 2007, 133:1293-1303. 10.1053/j.gastro.2007.06.062, 17919500.
25. Aoki H, Ohnishi H, Hama K, Ishijima T, Satoh Y, Hanatsuka K, Ohashi A, Wada S, Miyata T, Kita H, Yamamoto H, Osawa H, Sato K, Tamada K, Yasuda H, Mashima H, Sugano K. Autocrine loop between TGF-beta1 and IL-1beta through Smad3-and ERK-dependent pathways in rat pancreatic stellate cells. Am J Physiol Cell Physiol 2006, 290:C1100-1108.
26. Phillips PA, Wu MJ, Kumar RK, Doherty E, McCarroll JA, Park S, Pirola RC, Wilson JS, Apte MV. Cell migration: a novel aspect of pancreatic stellate cell biology. Gut 2003, 52:677-682. 10.1136/gut.52.5.677, 1773645, 12692052.
27. Shimizu K, Kobayashi M, Tahara J, Shiratori K. Cytokines and peroxisome proliferator activated receptor gamma ligand regulate phagocytosis by pancreatic stellate cells. Gastroenterology 2005, 128:2105-2118. 10.1053/j.gastro.2005.03.025, 15940641.
28. Masamune A, Kikuta K, Watanabe T, Satoh K, Satoh A, Shimosegawa T. Pancreatic stellate cells express Toll-like receptors. J Gastroenterol 2008, 43:352-362. 10.1007/s00535-008-2162-0, 18592153.
29. Völzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005, 71:97-105. 10.1159/000084525, 15775677.
30. Keller J, Aghdassi AA, Lerch MM, Mayerle JV, Layer P. Tests of pancreatic exocrine function-clinical significance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol 2009, 23:425-439. 10.1016/j.bpg.2009.02.013, 19505669.
31. Andersen DK. Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Pancreas 2007, 35:1-15. 10.1097/mpa.0b013e31805d01b0, 17575539.
32. Lieber CS, Jones DP, Decarli LM. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest 1965, 44:1009-1021. 10.1172/JCI105200, 292581, 14322019.
33. Thrower E, Husain S, Gorelick F. Molecular basis for pancreatitis. Curr Opin Gastroenterol 2008, 24:580-585. 10.1097/MOG.0b013e32830b10e6, 3030809, 19122498.
34. Opie EL. The relation of cholelithiasis to disease of the pancreas and to fat necrosis. Johns Hopkins Hosp Bull 1901, 12:19-21.
35. Opie EL. The etiology of acute hemorrhagic pancreatitis. Johns Hopkins Hosp Bull 1901, 12:182-188.
36. Lerch MM, Saluja AK, Dawra R, Ramarao P, Saluja M, Steer ML. Acute necrotizing pancreatitis in the opossum: earliest morphological changes involve acinar cells. Gastroenterology 1992, 103:205-213.
37. Lerch MM, Saluja AK, Runzi M, Dawra R, Saluja M, Steer ML. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum. Gastroenterology 1993, 104:853-861.
38. Seidel H. Bemerkungen zu meiner Methode der experimentellen Erzeugung der akuten hämorrhagischen Pankreatitis. Zentralbl der Chir 1910, 2:46-59.
39. Pfeffer RB, Stasior O, Hinton JW. The clinical picture of the sequential development of acute hemorrhagic pancreatitis in the dog. Surg Forum 1957, 8:248-251.
40. De Rai P, Franciosi C, Confalonieri GM, Biffi R, Andreoni B, Uggeri F, Malesci A. Effects of somatostatin on acute pancreatitis induced in rats by injection of taurocholate and trypsin into a temporarily closed duodenal loop. Int J Pancreatol 1988, 3:367-373.
41. Klein ES, Grateron H, Rudick J, Dreiling DA. Pancreatic intraductal pressure: I. A consideration of regulatory factors. Am J Gastroenterol 1983, 78:507-509.
42. Stone HH, Fabian TC, Dunlop WE. Gallstone pancreatitis: biliary tract pathology in relation to time of operation. Ann Surg 1981, 194:305-312. 10.1097/00000658-198109000-00008, 1345356, 6168240.
43. Churg A, Richter WR. Early changes in the exocrine pancreas of the dog and rat after ligation of the pancreatic duct. A light and electron microscopic study. Am J Pathol 1971, 63:521-546. 2047483, 5581235.
44. Watanabe S, Abe K, Anbo Y, Katoh H. Changes in the mouse exocrine pancreas after pancreatic duct ligation: a qualitative and quantitative histological study. Arch Histol Cytol 1995, 58:365-374. 10.1679/aohc.58.365, 8527243.
45. Kimura W. Histological study on pathogenesis of sites of isolated islets of Langerhans and their course to the terminal state. Am J Gastroenterol 1989, 84:517-522.
46. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973, 288:813-815. 10.1056/NEJM197304192881603, 4693931.
47. Tanaka T, Ichiba Y, Fujii Y, Itoh H, Kodama O, Dohi K. New canine model of chronic pancreatitis due to chronic ischemia with incomplete pancreatic duct obstruction. Digestion 1988, 41:149-155. 10.1159/000199767, 3224767.
48. Tanaka T, Miura Y, Matsugu Y, Ichiba Y, Ito H, Dohi K. Pancreatic duct obstruction is an aggravating factor in the canine model of chronic alcoholic pancreatitis. Gastroenterology 1998, 115:1248-1253. 10.1016/S0016-5085(98)70097-6, 9797381.
49. Hirano T, Saluja A, Ramarao P, Lerch MM, Saluja M, Steer ML. Apical secretion of lysosomal-enzymes in rabbit pancreas occurs via a secretagogue regulated pathway and is increased after pancreatic duct obstruction. J Clin Invest 1991, 87:865-869. 10.1172/JCI115091, 329875, 1705567.
50. Mooren F, Hlouschek V, Finkes T, Turi S, Weber IA, Singh J, Domschke W, Schnekenburger J, Krüger B, Lerch MM. Early changes in pancreatic acinar cell calcium signaling after pancreatic duct obstruction. J Biol Chem 2003, 278:9361-9369. 10.1074/jbc.M207454200, 12522141.
51. Boerma D, Straatsburg IH, Offerhaus GJ, Gouma DJ, van Gulik TM. Experimental model of obstructive, chronic pancreatitis in pigs. Dig Surg 2003, 20:520-526. 10.1159/000073688, 14534374.
52. Kishi S, Takeyama Y, Ueda T, Yasuda T, Shinzeki M, Kuroda Y, Yokozaki H. Pancreatic duct obstruction itself induces expression of alpha smooth muscle actin in pancreatic stellate cells. J Surg Res 2003, 114:6-14. 10.1016/S0022-4804(03)00153-7, 13678692.
53. Isaksson G, Lundquist I, Ihse I. Effects on the exocrine and endocrine pancreas of duct occlusion with two different tissue glues in the rat. Eur Surg Res 1983, 15:136-144. 10.1159/000128345, 6345169.
54. Engel SRW, Dockerty MB. Effect of ligation of pancreatic ducts on chronic pancreatitis. Arch Surg 1962, 85:1031-1035.
55. Chiari H. Über die Selbstverdauung des menschlichen Pankreas. Z Heilk 1896, 17:69-96.
56. Kruger B, Lerch MM, Tessenow W. Direct detection of premature protease activation in living pancreatic acinar cells. Lab Invest 1998, 78:763-764.
57. Foulis AK. Histological evidence of initiating factors in acute necrotising pancreatitis in man. J Clin Pathol 1980, 33:1125-1131. 10.1136/jcp.33.12.1125, 1146363, 7451660.
58. Bialek R, Willemer S, Arnold R, Adler G. Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats. Scand J Gastroenterol 1991, 26:190-196. 10.3109/00365529109025030, 1707179.
59. Luthen R, Niederau C, Grendell JH. Intrapancreatic zymogen activation and levels of ATP and glutathione during caerulein pancreatitis in rats. Am J Physiol 1995, 268:G592-604.
60. Rinderknecht H. Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci 1986, 31:314-321. 10.1007/BF01318124, 2936587.
61. Mouret J. Contribution á l'étude des cellules glandulaires (pancreas). J Anat Physiol 1895, 31:221-236.
62. Adler G, Gerhards G, Schick J, Rohr G, Kern HF. Effects of in vivo cholinergic stimulation of rat exocrine pancreas. Am J Physiol 1983, 244:G623-629.
63. Niederau C, Ferrell LD, Grendell JH. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 1985, 88:1192-1204.
64. Saluja A, Saito I, Saluja M, Houlihan MJ, Powers RE, Meldolesi J, Steer M. In vivo rat pancreatic acinar cell function during supramaximal stimulation with caerulein. Am J Physiol 1985, 249:G702-710.
65. Watanabe O, Baccino FM, Steer ML, Meldolesi J. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol 1984, 246:G457-467.
66. Pantoja JL, Renner IG, Abramson SB, Edmondson HA. Production of acute hemorrhagic pancreatitis in the dog using venom of the scorpion, Buthus quinquestriatus. Dig Dis Sci 1983, 28:429-439. 10.1007/BF02430532, 6839906.
67. Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD. Human pancreatic acinar cells do not respond to cholecystokinin. Pharmacol Toxicol 2002, 91:327-332. 10.1034/j.1600-0773.2002.910610.x, 12688376.
68. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch A Pathol Anat Histol 1977, 373:97-117. 10.1007/BF00432156, 139754.
69. Scheele GA, Palade GE. Studies on the guinea pig pancreas. Parallel discharge of exocrine enzyme activities. J Biol Chem 1975, 250:2660-2670.
70. Lerch MM, Albrecht E, Ruthenburger M, Mayerle J, Halangk W, Kruger B. Pathophysiology of alcohol-induced pancreatitis. Pancreas 2003, 27:291-296. 10.1097/00006676-200311000-00003, 14576489.
71. Lerch MM, Lutz MP, Weidenbach H, Muller-Pillasch F, Gress TM, Leser J, Adler G. Dissociation and reassembly of adherens junctions during experimental acute pancreatitis. Gastroenterology 1997, 113:1355-1366. 10.1053/gast.1997.v113.pm9322531, 9322531.
72. Lerch MM, Saluja AK, Runzi M, Dawra R, Steer ML. Luminal endocytosis and intracellular targeting by acinar cells during early biliary pancreatitis in the opossum. J Clin Invest 1995, 95:2222-2231. 10.1172/JCI117912, 295834, 7537759.
73. Lerch MM, Saluja AK, Dawra R, Saluja M, Steer ML. The effect of chloroquine administration on two experimental models of acute pancreatitis. Gastroenterology 1993, 104:1768-1779.
74. Adler G, Rohr G, Kern HF. Alteration of membrane fusion as a cause of acute pancreatitis in the rat. Dig Dis Sci 1982, 27:993-1002. 10.1007/BF01391745, 7140496.
75. Shimizu K. Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol 2008, 43:823-832. 10.1007/s00535-008-2249-7, 19012035.
76. Gress T, Muller-Pillasch F, Elsasser HP, Bachem M, Ferrara C, Weidenbach H, Lerch M, Adler G. Enhancement of transforming growth factor beta 1 expression in the rat pancreas during regeneration from caerulein-induced pancreatitis. Eur J Clin Invest 1994, 24:679-685. 10.1111/j.1365-2362.1994.tb01060.x, 7851468.
77. Menke A, Yamaguchi H, Gress TM, Adler G. Extracellular matrix is reduced by inhibition of transforming growth factor beta1 in pancreatitis in the rat. Gastroenterology 1997, 113:295-303. 10.1016/S0016-5085(97)70107-0, 9207290.
78. Neuschwander-Tetri BA, Burton FR, Presti ME, Britton RS, Janney CG, Garvin PR, Brunt EM, Galvin NJ, Poulos JE. Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse. Dig Dis Sci 2000, 45:665-674. 10.1023/A:1005423122127, 10759232.
79. Iovanna JL, Odaira C, Berger Z, Sarles H. Temporary pseudochronic lesions during the recovery of acute necrohemorrhagic pancreatitis in rabbits. Pancreas 1988, 3:433-438. 10.1097/00006676-198808000-00011, 3174606.
80. Bockman DE, Boydston WR, Anderson MC. Origin of tubular complexes in human chronic pancreatitis. Am J Surg 1982, 144:243-249. 10.1016/0002-9610(82)90518-9, 7102934.
81. Miyahara T, Kawabuchi M, Goto M, Nakano I, Nada O, Nawata H. Morphological study of pancreatic endocrine in an experimental chronic pancreatitis with diabetes induced by stress and cerulein. Ultrastruct Pathol 1999, 23:171-180. 10.1080/019131299281671, 10445284.
82. Goto M, Nakano I, Kimura T, Miyahara T, Kinjo M, Nawata H. New chronic pancreatitis model with diabetes induced by cerulein plus stress in rats. Dig Dis Sci 1995, 40:2356-2363. 10.1007/BF02063237, 7587814.
83. Ohashi S, Nishio A, Nakamura H, Asada M, Tamaki H, Kawasaki K, Fukui T, Yodoi J, Chiba T. Overexpression of redox-active protein thioredoxin-1 prevents development of chronic pancreatitis in mice. Antioxid Redox Signal 2006, 8:1835-1845. 10.1089/ars.2006.8.1835, 16987036.
84. Sugiyama M, Kobori O, Atomi Y, Wada N, Kuroda A, Muto T. Pancreatic exocrine function during acute exacerbation in WBN/Kob rats with spontaneous chronic pancreatitis. Int J Pancreatol 1996, 20:191-196. 10.1007/BF02803768, 9013280.
85. Elsasser HP, Haake T, Grimmig M, Adler G, Kern HF. Repetitive cerulein-induced pancreatitis and pancreatic fibrosis in the rat. Pancreas 1992, 7:385-390. 10.1097/00006676-199205000-00017, 1594561.
86. Miyamoto T, Nakamura H, Nagashio Y, Asaumi H, Harada M, Otsuki M. Overexpression of Smad6 exacerbates pancreatic fibrosis in murine caerulein-induced chronic pancreatic injuries. Pancreas 2010, 39:385-391. 10.1097/MPA.0b013e3181bb9603, 19823096.
87. Dawra R, Sharif R, Phillips P, Dudeja V, Dhaulakhandi D, Saluja AK. Development of a new mouse model of acute pancreatitis induced by administration of l-arginine. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1009-1018.
88. Takacs T, Czako L, Morschl E, Laszlo F, Tiszlavicz L, Rakonczay Z, Lonovics J. The role of nitric oxide in edema formation in l-arginine-induced acute pancreatitis. Pancreas 2002, 25:277-282. 10.1097/00006676-200210000-00010, 12370539.
89. Hegyi P, Rakonczay Z, Sari R, Gog C, Lonovics J, Takacs T, Czako L. l-Arginine induced experimental pancreatitis. World J Gastroenterol 2004, 10:2003-2009.
90. Mizunuma T, Kawamura S, Kishino Y. Effects of injecting excess arginine on rat pancreas. J Nutr 1984, 114:467-471.
91. Tani S, Itoh H, Okabayashi Y, Nakamura T, Fujii M, Fujisawa T, Koide M, Otsuki M. New model of acute necrotizing pancreatitis induced by excessive doses of arginine in rats. Dig Dis Sci 1990, 35:367-374. 10.1007/BF01537416, 2307082.
92. Delaney CP, McGeeney KF, Dervan P, Fitzpatrick JM. Pancreatic atrophy: a new model using serial intra-peritoneal injections of l-arginine. Scand J Gastroenterol 1993, 28:1086-1090. 10.3109/00365529309098314, 8303212.
93. Weaver C, Bishop AE, Polak JM. Pancreatic changes elicited by chronic administration of excess l-arginine. Exp Mol Pathol 1994, 60:71-87. 10.1006/exmp.1994.1007, 8070543.
94. Yamaguchi T, Kihara Y, Taguchi M, Nagashio Y, Tashiro M, Nakamura H, Otsuki M. Persistent destruction of the basement membrane of the pancreatic duct contributes to progressive acinar atrophy in rats with experimentally induced pancreatitis. Pancreas 2005, 31:365-372. 10.1097/01.mpa.0000179729.61457.e5, 16258372.
95. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433. 10.1126/science.1698311, 1698311.
96. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
97. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002, 3:667-672.
98. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 2000, 12:113-117. 10.1093/intimm/12.1.113, 10607756.
99. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11:115-122. 10.1016/S1074-7613(00)80086-2, 10435584.
100. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997, 91:243-252. 10.1016/S0092-8674(00)80406-7, 9346241.
101. Ding SP, Li JC, Jin C. A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J Gastroenterol 2003, 9:584-589.
102. Segersvard R, Sylvan M, Lempinen M, Larsson J, Permert J. Impact of chronic and acute high-fat feeding on acute experimental pancreatitis complicated by endotoxinaemia. Scand J Gastroenterol 2004, 39:74-80. 10.1080/00365520310007233, 14992565.
103. Vaquero E, Molero X, Tian X, Salas A, Malagelada JR. Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats. Gut 1999, 45:269-277. 10.1136/gut.45.2.269, 1727609, 10403741.
104. Gukovsky I, Lugea A, Shahsahebi M, Cheng JH, Hong PP, Jung YJ, Deng QG, French BA, Lungo W, French SW, Tsukamoto H, Pandol SJ. A rat model reproducing key pathological responses of alcoholic chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2008, 294:G68-79.
105. Hirakawa K, Ohkuma S, Kuriyama K. Functional and morphological changes of the exocrine pancreas in ciclosporin-treated rats. Eur Surg Res 1991, 23:292-301. 10.1159/000129167, 1724964.
106. Sparmann G, Merkord J, Jaschke A, Nizze H, Jonas L, Lohr M, Liebe S, Emmrich J. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 1997, 112:1664-1672. 10.1016/S0016-5085(97)70049-0, 9136846.
107. Merkord J, Weber H, Kroning G, Hennighausen G. Repeated administration of a mild acute toxic dose of di-N-butyltin dichloride at intervals of 3 weeks induces severe lesions in pancreas and liver of rats. Hum Exp Toxicol 2001, 20:386-392. 10.1191/096032701682692964, 11727788.
108. Merkord J, Weber H, Sparmann G, Jonas L, Hennighausen G. The course of pancreatic fibrosis induced by dibutyltin dichloride (DBTC). Ann N Y Acad Sci 1999, 880:231-237. 10.1111/j.1749-6632.1999.tb09527.x, 10415868.
109. Leung PS, Chan YC. Role of oxidative stress in pancreatic inflammation. Antioxid Redox Signal 2009, 11:135-165. 10.1089/ars.2008.2109, 18837654.
110. Wildi S, Kleeff J, Mayerle J, Zimmermann A, Böttinger EP, Wakefield L, Büchler MW, Friess H, Korc M. Suppression of transforming growth factor beta signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations. Gut 2007, 56:685-692. 10.1136/gut.2006.105833, 1942167, 17135311.
111. He J, Sun X, Qian KQ, Liu X, Wang Z, Chen Y. Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7. Biochim Biophys Acta 2009, 1792:56-60.
112. Li J, Guo M, Hu B, Liu R, Wang R, Tang C. Does chronic ethanol intake cause chronic pancreatitis?: evidence and mechanism. Pancreas 2008, 37:189-195. 10.1097/MPA.0b013e31816459b7, 18665082.
113. Vonlaufen A, Wilson JS, Apte MV. Molecular mechanisms of pancreatitis: current opinion. J Gastroenterol Hepatol 2008, 23:1339-1348. 10.1111/j.1440-1746.2008.05520.x, 18853993.
114. Gukovskaya AS, Mouria M, Gukovsky I, Reyes CN, Kasho VN, Faller LD, Pandol SJ. Ethanol metabolism and transcription factor activation in pancreatic acinar cells in rats. Gastroenterology 2002, 122:106-118. 10.1053/gast.2002.30302, 11781286.
115. Ponnappa BC, Marciniak R, Schneider T, Hoek JB, Rubin E. Ethanol consumption and susceptibility of the pancreas to cerulein-induced pancreatitis. Pancreas 1997, 14:150-157. 10.1097/00006676-199703000-00007, 9057187.
116. Lieber CS, DeCarli LM. Alcoholic liver injury: experimental models in rats and baboons. Adv Exp Med Biol 1975, 59:379-393.
117. Lieber CS, Decarli LM. Animal models of ethanol dependence and liver injury in rats and baboons. Fed Proc 1976, 35:1232-1236.
118. Sarles H, Lebreuil G, Tasso F, Figarella C, Clemente F, Devaux MA, Fagonde B, Payan H. A comparison of alcoholic pancreatitis in rat and man. Gut 1971, 12:377-388. 10.1136/gut.12.5.377, 1411611, 4329553.
119. Tsukamoto H, Towner SJ, Yu GS, French SW. Potentiation of ethanol-induced pancreatic injury by dietary fat. Induction of chronic pancreatitis by alcohol in rats. Am J Pathol 1988, 131:246-257. 1880607, 3358454.
120. Deng X, Wang L, Elm MS, Gabazadeh D, Diorio GJ, Eagon PK, Whitcomb DC. Chronic alcohol consumption accelerates fibrosis in response to cerulein-induced pancreatitis in rats. Am J Pathol 2005, 166:93-106. 10.1016/S0002-9440(10)62235-3, 1602301, 15632003.
121. Perides G, Tao X, West N, Sharma A, Steer ML. A mouse model of ethanol dependent pancreatic fibrosis. Gut 2005, 54:1461-1467. 10.1136/gut.2004.062919, 1774704, 15870229.
122. Perkins PS, Rutherford RE, Pandol SJ. Effect of chronic ethanol feeding on digestive enzyme synthesis and mRNA content in rat pancreas. Pancreas 1995, 10:14-21. 10.1097/00006676-199501000-00002, 7899455.
123. Kobori O, Gedigk P, Totovic V. Adenomatous changes and adenocarcinoma of glandular stomach in Wistar rats induced by N-methyl-N'-nitro-N-nitrosoguanidine. An electron microscopic and histochemical study. Virchows Arch A Pathol Anat Histol 1977, 373:37-54. 10.1007/BF00432467, 139023.
124. Tsuchitani M, Saegusa T, Narama I, Nishikawa T, Gonda T. A new diabetic strain of rat (WBN/Kob). Lab Anim 1985, 19:200-207. 10.1258/002367785780893575, 4033061.
125. Ohashi K, Kim JH, Hara H, Aso R, Akimoto T, Nakama K. WBN/Kob rats. A new spontaneously occurring model of chronic pancreatitis. Int J Pancreatol 1990, 6:231-247.
126. Hashimoto T, Yamada T, Yokoi T, Sano H, Ando H, Nakazawa T, Ohara H, Nomura T, Joh T, Itoh M. Apoptosis of acinar cells is involved in chronic pancreatitis in Wbn/Kob rats: role of glucocorticoids. Pancreas 2000, 21:296-304. 10.1097/00006676-200010000-00012, 11039475.
127. Mori M, Fu X, Chen L, Zhang G, Higuchi K. Hereditary pancreatitis model WBN/Kob rat strain has a unique haplotype in the Pdwk1 region on chromosome 7. Exp Anim 2009, 58:409-413. 10.1538/expanim.58.409, 19654439.
128. O'Toole JF, Liu Y, Davis EE, Westlake CJ, Attanasio M, Otto EA, Seelow D, Nurnberg G, Becker C, Nuutinen M, Kärppä M, Ignatius J, Uusimaa J, Pakanen S, Jaakkola E, van den Heuvel LP, Fehrenbach H, Wiggins R, Goyal M, Zhou W, Wolf MT, Wise E, Helou J, Allen SJ, Murga-Zamalloa CA, Ashraf S, Chaki M, Heeringa S, Chernin G, Hoskins BE, et al. Individuals with mutations in XPNPEP3, which encodes a mitochondrial protein, develop a nephronophthisis-like nephropathy. J Clin Invest 2010, 120:791-802. 10.1172/JCI40076, 2827951, 20179356.
129. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141-145. 10.1038/ng1096-141, 8841182.
130. Selig L, Sack U, Gaiser S, Kloppel G, Savkovic V, Mossner J, Keim V, Bodeker H. Characterisation of a transgenic mouse expressing R122H human cationic trypsinogen. BMC Gastroenterol 2006, 6:30. 10.1186/1471-230X-6-30, 1637108, 17069643.
131. Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology 2006, 131:1844-1855. 10.1053/j.gastro.2006.09.049, 17087933.
132. Gaiser S, Daniluk J, Liu Y, Tsou L, Chu J, Lee W, Longnecker DS, Logsdon CD, Ji B. Intracellular activation of trypsinogen in transgenic mice induces acute but not chronic pancreatitis. Gut 2011, 60:1379-1388. 10.1136/gut.2010.226175, 21471572.
133. Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: Guidelines for indications, counselling, consent and privacy issues. Pancreatology 2001, 1:405-415. 10.1159/000055840, 12120217.
134. Keim V, Bauer N, Teich N, Simon P, Lerch MM, Mössner J. Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med 2001, 111:622-626. 10.1016/S0002-9343(01)00958-5, 11755505.
135. Ohmuraya M, Hirota M, Araki K, Baba H, Yamamura K. Enhanced trypsin activity in pancreatic acinar cells deficient for serine protease inhibitor kazal type 3. Pancreas 2006, 33:104-106. 10.1097/01.mpa.0000226889.86322.9b, 16804421.
136. Ohmuraya M, Hirota M, Araki M, Mizushima N, Matsui M, Mizumoto T, Haruna K, Kume S, Takeya M, Ogawa M, Araki K, Yamamura K. Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice. Gastroenterology 2005, 129:696-705.
137. Nathan JD, Romac J, Peng RY, Peyton M, Macdonald RJ, Liddle RA. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice. Gastroenterology 2005, 128:717-727. 10.1053/j.gastro.2004.11.052, 15765407.
138. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073. 10.1126/science.2475911, 2475911.
139. Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002, 123:1857-1864. 10.1053/gast.2002.37042, 12454843.
140. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. An animal model for cystic fibrosis made by gene targeting. Science 1992, 257:1083-1088. 10.1126/science.257.5073.1083, 1380723.
141. De Lisle RC, Isom KS, Ziemer D, Cotton CU. Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse. Am J Physiol Gastrointest Liver Physiol 2001, 281:G899-906.
142. Dimagno MJ, Lee SH, Hao Y, Zhou SY, McKenna BJ, Owyang C. A proinflammatory, antiapoptotic phenotype underlies the susceptibility to acute pancreatitis in cystic fibrosis transmembrane regulator (-/-) mice. Gastroenterology 2005, 129:665-681.
143. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB, Zabner J, Prather RS, Welsh MJ. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 2008, 321:1837-1841. 10.1126/science.1163600, 2570747, 18818360.
144. Cano DA, Sekine S, Hebrok M. Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis. Gastroenterology 2006, 131:1856-1869. 10.1053/j.gastro.2006.10.050, 17123526.
145. Lin F, Hiesberger T, Cordes K, Sinclair AM, Goldstein LS, Somlo S, Igarashi P. Kidney specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc Natl Acad Sci USA 2003, 100:5286-5291. 10.1073/pnas.0836980100, 154337, 12672950.
146. Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, Ron D. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/-mice reveals a role for translational control in secretory cell survival. Mol Cell 2001, 7:1153-1163. 10.1016/S1097-2765(01)00264-7, 11430819.
147. Marrache F, Tu SP, Bhagat G, Pendyala S, Osterreicher CH, Gordon S, Ramanathan V, Penz-Osterreicher M, Betz KS, Song Z, Wang TC. Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis. Gastroenterology 2008, 135:1277-1287. 10.1053/j.gastro.2008.06.078, 2707078, 18789941.
148. Norman JG, Fink GW, Sexton C, Carter G. Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1beta gene expression at steady-state and during the systemic stress induced by acute pancreatitis. J Surg Res 1996, 63:231-236. 10.1006/jsre.1996.0253, 8661203.
149. Hunger RE, Mueller C, Z'Graggen K, Friess H, Buchler MW. Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology 1997, 112:1656-1663. 10.1016/S0016-5085(97)70048-9, 9136845.